iOrganBio: Funding, Investors & Team (Sep 2026)
iOrganBio is a pioneering cell production platform.
iOrganBio has raised $2.0M across 1 funding round on record, the most recent a Seed of $2.0M announced in Oct 2025.
That round is below the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
iOrganBio Company Profile and Key Stats
Latest funding round on record: Oct 2025.
iOrganBio Funding Rounds
iOrganBio Founders and Leadership Team
Contact details for the iOrganBio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →iOrganBio Funding Compared to Other Biotechnology Startups
iOrganBio's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like iOrganBio in Biotechnology and Chapel Hill
Companies Similar to iOrganBio
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Rion Vet mission is to drive the regenerative medicine revolution.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
NILO Therapeutics is a biotechnology and therapeutics company.
AccufyDx is a Biotechnology Research firm working to change MRD analysis for early detection.Accufy…
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Reprogenix is a groundbreaking medical technology firm
iOrganBio Funding FAQs
What does iOrganBio do?
iOrganBio is a pioneering cell production platform.
How much funding has iOrganBio raised?
iOrganBio has raised $2.0M across 1 round on record. The most recent is a Seed of $2.0M announced in Oct 2025.
When did iOrganBio last raise funding?
iOrganBio's most recent funding round on record is a Seed of $2.0M, announced in Oct 2025.
Who is the CEO of iOrganBio?
Daniel Delubac is listed as CEO at iOrganBio.
Where is iOrganBio headquartered?
iOrganBio is based in Chapel Hill, United States.
How many employees does iOrganBio have?
iOrganBio is in the 1-10 employee band.
How does iOrganBio's funding compare to other Biotechnology startups?
iOrganBio's latest round of $2.0M is below the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's iOrganBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iOrganBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.